ABELZETA
Live / Applied — Second extension granted (statement of use) (as of 12 Dec 2025)
What this means for you
Not registered yet, but its 10 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98350102
- Mark type
- Design + words
- Filed
- 10 Jan 2024
- Published for opposition
- 12 Nov 2024
- Attorney of record
- Lauren Beth Emerson
Goods and services
- Class 001 — Chemicals: Excipients for use in the manufacture of pharmaceutical and biological preparations for research and medical use; biological preparations, namely, viral vectors and plasmids for research
- Class 005 — Pharmaceuticals: Pharmaceutical and biological preparations for medical use, namely, for the treatment and prevention of diseases, namely, cancer and autoimmune diseases; pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment of cancer; pharmaceutical and biological preparations for immunotherapy; pharmaceutical and biological preparations for medical diagnostic use; diagnostic kits consisting primarily of cells for medical or clinical use; biological preparations, namely, viral vectors and plasmids for medical use for the treatment of cancer and autoimmune diseases; cells for medical use
- Class 040 — Treatment of materials: Custom manufacturing of biological tissue, blood, and cells; custom manufacturing of pharmaceutical preparations for immunotherapy; custom manufacture of pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of cancer and autoimmune diseases; custom manufacture of viral vectors and plasmids for research and clinical use; custom manufacture of excipients for use in the manufacture of pharmaceutical and biological preparations for research and medical use
- Class 042 — Scientific and technological services: Research and development of new products for others; scientific research; gene therapy research; research in the field of cell engineering technology; stem cell research services; scientific research in the field of genetics; biomedical research services; medical research; biological research; providing medical and scientific research information in the field of clinical trials; culturing of cells for others for scientific research purposes
- Class 044 — Medical, beauty and agricultural services: Cell therapy services, namely, immune cell therapy services and medical treatment using cultured cells; collection and preservation of biological tissue, blood and cells; providing medical information; providing health information in the field of oncology; providing medical information in the field of pharmaceuticals and cell therapy; medical treatment services; medical diagnostic services
Owner
- ABELZETA INC., ROCKVILLE, MD, US
- ABELZETA INC., ROCKVILLE, MD, US
Prosecution history
- 12 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Dec 2025 — SOU EXTENSION 2 GRANTED
- 10 Dec 2025 — SOU EXTENSION 2 FILED
- 10 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Nov 2025 — CORRECTED NOA E-MAILED
- 25 Nov 2025 — SOU EXTENSION 1 GRANTED
- 02 Jun 2025 — SOU EXTENSION 1 FILED
- 25 Nov 2025 — DIVISIONAL PROCESSING COMPLETE
- 03 Jun 2025 — DIVISIONAL REQUEST RECEIVED
- 24 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Jun 2025 — TEAS REQUEST TO DIVIDE RECEIVED